Updated May 26, 2007 at 22:33 EST.
Vectura, the company currently developing an inhalable treatment for premature ejaculation ( PE ), is looking for a large pharmaceutical company to assist with development and financing of clinical trials. Although talks are still in progress, companies that currently manufacture erectile dysfunction drugs like have been mentioned as part of the negotiation process.
Initial results from the inhaled form of the drug indicate that men who used it experienced positive results within 15 minutes. There are no drugs currently approved specifically to treat premature ejaculation ( PE ) . Vectura is based in the
UK and is interested in pursuing the market world-wide. The company also has an inhaled form of an erectile dysfunction drug that is in the testing phase and is included in the current business plans.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
